BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7763254)

  • 1. Point mutation of the somatostatin receptor 2 gene in the human small cell lung cancer cell line COR-L103.
    Zhang CY; Yokogoshi Y; Yoshimoto K; Fujinaka Y; Matsumoto K; Saito S
    Biochem Biophys Res Commun; 1995 May; 210(3):805-15. PubMed ID: 7763254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium ionophore A23187 inhibits ACTH secretion from a human small cell lung cancer cell line, COR-L103.
    Zhang CY; Fujinaka Y; Yokogoshi Y; Saito S
    Biochem Biophys Res Commun; 1995 Feb; 207(1):238-43. PubMed ID: 7857271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression of somatostatin receptor subtypes, SSTR1 and SSTR2, in human lung cancer cell lines.
    Fujita T; Yamaji Y; Sato M; Murao K; Takahara J
    Life Sci; 1994; 55(23):1797-806. PubMed ID: 7968260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoid inhibition of ACTH peptides: small cell lung cancer cell lines are more resistant than pituitary corticotroph adenoma cells.
    Farrell WE; Stewart MF; Clark AJ; Crosby SR; Davis JR; White A
    J Mol Endocrinol; 1993 Feb; 10(1):25-32. PubMed ID: 8383976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of multiple somatostatin receptor genes in AtT-20 cells. Evidence for a novel somatostatin-28 selective receptor subtype.
    Patel YC; Panetta R; Escher E; Greenwood M; Srikant CB
    J Biol Chem; 1994 Jan; 269(2):1506-9. PubMed ID: 7904601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct functional properties of native somatostatin receptor subtype 5 compared with subtype 2 in the regulation of ACTH release by corticotroph tumor cells.
    van der Hoek J; Waaijers M; van Koetsveld PM; Sprij-Mooij D; Feelders RA; Schmid HA; Schoeffter P; Hoyer D; Cervia D; Taylor JE; Culler MD; Lamberts SW; Hofland LJ
    Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E278-87. PubMed ID: 15769796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective glucocorticoid regulation of proopiomelanocortin gene expression and peptide secretion in a small cell lung cancer cell line.
    Clark AJ; Stewart MF; Lavender PM; Farrell W; Crosby SR; Rees LH; White A
    J Clin Endocrinol Metab; 1990 Feb; 70(2):485-90. PubMed ID: 1967615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular cloning and expression of a pituitary somatostatin receptor with preferential affinity for somatostatin-28.
    O'Carroll AM; Lolait SJ; König M; Mahan LC
    Mol Pharmacol; 1992 Dec; 42(6):939-46. PubMed ID: 1362243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin-14 mainly binds the somatostatin receptor subtype 2 in human neuroblastoma tumors.
    Prevost G; Veber N; Viollet C; Roubert V; Roubert P; Benard J; Eden P
    Neuroendocrinology; 1996 Feb; 63(2):188-97. PubMed ID: 9053784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphine cross-reacts with somatostatin receptor SSTR2 in the T47D human breast cancer cell line and decreases cell growth.
    Hatzoglou A; Ouafik L; Bakogeorgou E; Thermos K; Castanas E
    Cancer Res; 1995 Dec; 55(23):5632-6. PubMed ID: 7585646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between receptor binding and biopotency of somatostatin-14 and somatostatin-28 in mouse pituitary tumor cells.
    Srikant CB; Heisler S
    Endocrinology; 1985 Jul; 117(1):271-8. PubMed ID: 2861078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of somatostatin receptor subtype 2 (SSTR2) in established tumors and tumor cell lines: evidence for SSTR2 heterogeneity.
    Taylor JE; Theveniau MA; Bashirzadeh R; Reisine T; Eden PA
    Peptides; 1994; 15(7):1229-36. PubMed ID: 7854974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photoaffinity labeling of the somatostatin receptor: identification of molecular subtypes.
    Srikant CB; Murthy KK; Escher EE; Patel YC
    Endocrinology; 1992 May; 130(5):2937-46. PubMed ID: 1349280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of SOM230 on adrenocorticotropic hormone production and corticotroph tumor cell proliferation in vitro and in vivo.
    Murasawa S; Kageyama K; Sugiyama A; Ishigame N; Niioka K; Suda T; Daimon M
    Mol Cell Endocrinol; 2014 Aug; 394(1-2):37-46. PubMed ID: 25011056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides.
    Raynor K; Murphy WA; Coy DH; Taylor JE; Moreau JP; Yasuda K; Bell GI; Reisine T
    Mol Pharmacol; 1993 Jun; 43(6):838-44. PubMed ID: 8100350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A human somatostatin receptor (SSTR3), located on chromosome 22, displays preferential affinity for somatostatin-14 like peptides.
    Corness JD; Demchyshyn LL; Seeman P; Van Tol HH; Srikant CB; Kent G; Patel YC; Niznik HB
    FEBS Lett; 1993 Apr; 321(2-3):279-84. PubMed ID: 8097479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin receptor subtypes in human thymoma and inhibition of cell proliferation by octreotide in vitro.
    Ferone D; van Hagen MP; Kwekkeboom DJ; van Koetsveld PM; Mooy DM; Lichtenauer-Kaligis E; Schönbrunn A; Colao A; Lamberts SW; Hofland LJ
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1719-26. PubMed ID: 10770220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5.
    Hofland LJ; van der Hoek J; Feelders R; van Aken MO; van Koetsveld PM; Waaijers M; Sprij-Mooij D; Bruns C; Weckbecker G; de Herder WW; Beckers A; Lamberts SW
    Eur J Endocrinol; 2005 Apr; 152(4):645-54. PubMed ID: 15817922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for multiple protein constituents of the somatostatin receptor in pituitary tumor cells: affinity cross-linking and molecular characterization.
    Murthy KK; Srikant CB; Patel YC
    Endocrinology; 1989 Aug; 125(2):948-56. PubMed ID: 2568926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of somatostatin receptor subtype (SSTR1-5) gene expression levels in somatotropinomas and non-functioning pituitary adenomas.
    Taboada GF; Luque RM; Bastos W; Guimarães RF; Marcondes JB; Chimelli LM; Fontes R; Mata PJ; Filho PN; Carvalho DP; Kineman RD; Gadelha MR
    Eur J Endocrinol; 2007 Jan; 156(1):65-74. PubMed ID: 17218727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.